ES2766424T3 - Preparación sólida que contienen agente oxidante - Google Patents

Preparación sólida que contienen agente oxidante Download PDF

Info

Publication number
ES2766424T3
ES2766424T3 ES16765092T ES16765092T ES2766424T3 ES 2766424 T3 ES2766424 T3 ES 2766424T3 ES 16765092 T ES16765092 T ES 16765092T ES 16765092 T ES16765092 T ES 16765092T ES 2766424 T3 ES2766424 T3 ES 2766424T3
Authority
ES
Spain
Prior art keywords
pharmaceutical preparation
solid pharmaceutical
tocopherol
preparation according
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES16765092T
Other languages
English (en)
Spanish (es)
Inventor
Shinichiro Tajiri
Jin Hisazumi
Shinji Yoshinaga
Hiroyuki Fujimori
Hiroaki Arai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56918879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2766424(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Application granted granted Critical
Publication of ES2766424T3 publication Critical patent/ES2766424T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
ES16765092T 2015-03-19 2016-03-17 Preparación sólida que contienen agente oxidante Active ES2766424T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015055768 2015-03-19
PCT/JP2016/058607 WO2016148263A1 (fr) 2015-03-19 2016-03-17 Préparation solide contenant un agent antioxydant

Publications (1)

Publication Number Publication Date
ES2766424T3 true ES2766424T3 (es) 2020-06-12

Family

ID=56918879

Family Applications (1)

Application Number Title Priority Date Filing Date
ES16765092T Active ES2766424T3 (es) 2015-03-19 2016-03-17 Preparación sólida que contienen agente oxidante

Country Status (10)

Country Link
US (1) US10561628B2 (fr)
EP (1) EP3272345B1 (fr)
JP (1) JP6630343B2 (fr)
KR (1) KR102426821B1 (fr)
CN (1) CN107405322B (fr)
BR (1) BR112017019918B1 (fr)
CA (1) CA2980096C (fr)
ES (1) ES2766424T3 (fr)
TW (1) TWI713506B (fr)
WO (1) WO2016148263A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12083226B2 (en) 2018-07-30 2024-09-10 Daiichi Sankyo Company, Limited Stabilizer-containing solid drug formulation
ES3025936T3 (en) 2019-12-23 2025-06-10 Daiichi Sankyo Co Ltd Film-coated tablets having smooth surface
JP7744908B2 (ja) 2020-07-27 2025-09-26 第一三共株式会社 ミロガバリンベシル酸塩を含有する口腔内崩壊錠
KR20260018020A (ko) 2023-06-02 2026-02-06 다이이찌 산쿄 가부시키가이샤 미로가발린을 함유하는 의약 조성물
CN119732941A (zh) * 2024-12-30 2025-04-01 上海博悦生物科技有限公司 含有苯磺酸美洛加巴林的药物组合物及其制备方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY100306A (en) 1985-12-18 1990-08-11 Kao Corp Anti-suntan cosmetic composition
DE3928183A1 (de) 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
ATE268178T1 (de) * 1997-07-11 2004-06-15 Toray Industries Stabile medizinische zusammenstellungen die 4,5- epoxymorphinanderivate enthalten
JPH11189547A (ja) 1997-12-26 1999-07-13 Taisho Pharmaceut Co Ltd 安定化されたニコランジル製剤及びその製造方法
ES2262528T3 (es) 1999-08-04 2006-12-01 Astellas Pharma Inc. Composiciones medicinales estables para administracion oral que utilizan oxidos de hierro.
JP2001064177A (ja) 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
JP4610834B2 (ja) 1999-11-11 2011-01-12 杏林製薬株式会社 経口固形製剤
JP2003104887A (ja) 2001-09-28 2003-04-09 Maruko Seiyaku Kk 光に安定なアラニジピン含有組成物
WO2003091346A1 (fr) * 2002-04-24 2003-11-06 Dsm Ip Assets B.V. Composition de revetement durcissable par rayonnement destinee a des fibres optiques, presentant des pertes d'attenuation reduites
ZA200409537B (en) 2003-01-31 2006-10-25 Yamanouchi Pharma Co Ltd Stable solid medicinal composition for oral administration
JP4783573B2 (ja) 2004-02-20 2011-09-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 ワルファリンカリウム含有医薬組成物とその製造方法
WO2006056874A1 (fr) 2004-11-25 2006-06-01 Pfizer Limited Forme saline
EA016713B1 (ru) 2005-10-31 2012-07-30 Кова Ко., Лтд. Таблетка с насечкой, обладающая превосходной фотостабильностью
PE20070702A1 (es) 2005-11-02 2007-07-20 Takeda Pharmaceutical COMPUESTOS DERIVADOS DE (TRIFLUOROMETOXI-FENIL)-ETILAMINO COMO INHIBIDORES DE LA ACETILCOLINESTERASA Y ANTAGONISTAS DEL RECEPTOR DE ADRENALINA alfa1
JP4691434B2 (ja) 2005-11-08 2011-06-01 東和薬品株式会社 安定化されたカベルゴリン固形製剤
JP5365777B2 (ja) 2006-09-15 2013-12-11 アステラス製薬株式会社 光に対して安定なラモセトロンの固形医薬組成物
EP2094260B1 (fr) 2006-12-19 2012-02-01 Ramot at Tel-Aviv University Ltd. Traitement du cancer du poumon
BR122013020635A2 (pt) * 2007-09-28 2019-08-06 Daiichi Sankyo Company, Limited Composto
JP5558023B2 (ja) * 2008-04-18 2014-07-23 第一三共株式会社 医薬品組成物
CA2734847C (fr) 2008-08-18 2016-08-30 Mitsubishi Shoji Foodtech Co., Ltd. Nouvel excipient pour la fabrication de comprimes de mannitol
US20110305758A1 (en) 2009-01-29 2011-12-15 Mitsuhiro Matono Orally disintegrating tablet having inner core
JP2010241796A (ja) 2009-03-17 2010-10-28 Daiichi Sankyo Co Ltd 二環性γ−アミノ酸誘導体含有医薬組成物
CA2756750C (fr) 2009-03-26 2014-05-13 Daiichi Sankyo Company, Limited Methode de production d'un derive d'acide g-amine bicyclique
JP5674666B2 (ja) 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
AU2010313075A1 (en) * 2009-10-26 2012-05-31 Alkem Laboratories Ltd. Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof
US20120294947A1 (en) * 2009-12-28 2012-11-22 Nipro Corporation Oral Preparation Having Improved Quality
CN102753521B (zh) * 2010-10-19 2013-07-10 学校法人青山学院 抗利什曼原虫化合物以及抗利什曼原虫药
MX2013006247A (es) * 2010-12-03 2014-01-31 Takeda Pharmaceutical Tableta oralmente desintegradora.
EP2649182A4 (fr) * 2010-12-10 2015-05-06 Alnylam Pharmaceuticals Inc Compositions et procédés pour l'augmentation de la production d'érythropoïétine (epo)
BR112013020634A2 (pt) * 2011-02-17 2016-10-25 Takeda Pharmaceutical método para produzir uma forma opticamente ativa de um composto, sal, complexo de rutênio, composto, e, cristal
KR101877868B1 (ko) 2011-08-08 2018-07-12 가부시키가이샤산와카가쿠켄큐쇼 아조세미드를 유효성분으로 하는 코팅제제
JP5844573B2 (ja) 2011-08-10 2016-01-20 共和薬品工業株式会社 ピタバスタチンを含有する錠剤
US8617610B2 (en) * 2012-05-21 2013-12-31 Dsm Nutritional Products Ag Compositions and methods for increasing the stability of food product additives
WO2014021282A1 (fr) * 2012-07-30 2014-02-06 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 Solution anti-trichophytique à usage externe
IN2014MN02116A (fr) * 2013-04-04 2015-09-04 Daiichi Sankyo Companyltd
CN107427483B (zh) 2015-03-19 2021-06-29 第一三共株式会社 含有着色剂的固体制剂

Also Published As

Publication number Publication date
WO2016148263A1 (fr) 2016-09-22
KR20170128319A (ko) 2017-11-22
BR112017019918A2 (pt) 2018-06-19
US20180042878A1 (en) 2018-02-15
CA2980096C (fr) 2019-12-17
EP3272345A4 (fr) 2018-08-01
KR102426821B1 (ko) 2022-07-28
JP6630343B2 (ja) 2020-01-15
CN107405322A (zh) 2017-11-28
BR112017019918B1 (pt) 2023-11-07
JPWO2016148263A1 (ja) 2017-12-28
EP3272345A1 (fr) 2018-01-24
TW201639554A (zh) 2016-11-16
EP3272345B1 (fr) 2019-10-16
CA2980096A1 (fr) 2016-09-22
HK1250013A1 (en) 2018-11-23
US10561628B2 (en) 2020-02-18
TWI713506B (zh) 2020-12-21
CN107405322B (zh) 2020-08-18

Similar Documents

Publication Publication Date Title
ES2766424T3 (es) Preparación sólida que contienen agente oxidante
CN104334169B (zh) 包含氨基羧酸盐的固体组合物
ES2821733T3 (es) Preparación sólida que contiene colorante
TWI845532B (zh) 含安定劑之醫藥品的固體製劑
KR20150102852A (ko) 무정형 솔리페나신 또는 그의 염을 포함하는 안정성이 증가된 고체분산체 조성물 및 그 제조방법
JP5900702B2 (ja) 経口投与用医薬組成物
HK1250013B (en) Solid preparation containing antioxidant agent
HK40003924A (en) Solid preparation containing colorant
HK40003924B (en) Solid preparation containing colorant
HK1204559B (en) Solid composition of amino carboxylate salt